Improving Quality of Life in Patients With CLL: Managing Side Effects From Targeted Therapy

Sorry, the video player failed to load.

Improving Quality of Life in Patients With CLL: Managing Side Effects From Targeted Therapy

Joanna Rhodes, MD, MSCE

May 30, 2023

Joanna Rhodes, MD, MSCE, remembers a patient who experienced muscle spasms from targeted agents for chronic lymphocytic leukemia and uses this experience to illustrate the importance of shared decision-making in managing treatment-related side effects effectively.

This experience has also led to several research projects by Dr Rhodes and has affected her day-to-day approach in optimizing patient care.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Improving Quality of Life in Patients With CLL: Managing Side Effects From Targeted Therapy - Medscape - May 30, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.